EGFR and ovarian carcinoma: The same investigators showed that SIP-SII binds to plasma membrane EGFR in ovarian cancer SKOV3 cells, hampering its activation and leading to downregulation of EGFR-mediated p38/MAPK and PI3K/Akt/mTOR cascades [15].